Here, we hypothesized that lentinan might also bind to the CD133 on the surface of CRC cells and inhibit its expression, thus affecting the downstream signal pathway and inhibiting the stemness of CRC cells, thereby exerting anti-tumor effects. This evidence concerns the gene PROM1 and colorectal carcinoma.